arrow
F

Francisco M. Marty

university of north carolina–chapel hill
H指数:67
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial
2023-04-191
OAAI
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
2022-01-27865
OAAI
Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation

无细胞DNA分析提示造血细胞移植的所有主要并发症

2022-01-2021
OAAI
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
2021-12-02178
OAAI
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?

侵袭性曲霉病2020共识定义的变化对临床试验设计的影响: 预防试验的意外后果?

2021-09-092
OAAI
American Society for Transplantation and Cellular Therapy Series: #3-Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation

美国移植和细胞治疗学会系列: #3-预防造血细胞移植后的巨细胞病毒感染和疾病

2021-09-0186
OAAI
Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study
2020-12-3017
OAAI